–
Acumen Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.6
FY22:
−45.2
FY23:
−61.1
FY24:
−114
FY25:
−124
(positive)
Change from FY21 to FY25
millions USD
FY21:
61.6
FY22:
−42.7
FY23:
−50.2
FY24:
−99.7
FY25:
−116
(positive)
Change from FY21 to FY25
millions USD
FY21:
−101
FY22:
−42.9
FY23:
−52.4
FY24:
−102
FY25:
−121
(positive)
Change from FY21 to FY25
millions USD
FY21:
−101
FY22:
−42.9
FY23:
−52.4
FY24:
−102
FY25:
−121
All amounts in millions USD